Claudio Isella

Citata da

	Tutte	Dal 2018
Citazioni	4464	3057
Indice H	31	28
i10-index	48	42

640

320

160

480

20092010201120122013201420152016201720182019202020212022202312 30 29 68 123 167 240 322 386 379 429 564 627 594 461

Accesso pubblico

Visualizza tutto

44 articoli

1 articolo

Disponibili

Non disponibili

In base ai mandati di finanziamento

Coautori

Enzo MedicoProfessor of Histology, University of Torino and Head of the Laboratory of Oncogenomics, CandioloEmail verificata su ircc.it
Andrea BertottiUniversity of Torino - School of MedicineEmail verificata su ircc.it
Livio TrusolinoProfessor, University of Torino School of Medicine, ItalyEmail verificata su ircc.it
Alberto BardelliUniversity of Torino - Candiolo Cancer Institute IRCCSEmail verificata su ircc.it
Paolo M ComoglioIFOM (FIRC Institute for Molecular Oncology)Email verificata su ircc.it
Giorgio CortiCandiolo Cancer InstituteEmail verificata su ircc.it
francesco sassiIRCC-University of Torino School of Medicine, Laboratory of Molecular Pharmacology ItalyEmail verificata su ircc.it
ELISA FICARRAFull Professor, Dept. of Engineering "Enzo Ferrari", University of Modena and Reggio Emilia, ItalyEmail verificata su unimore.it
Salvatore SienaUniversità degli Studi di Milano, Dipartimento di Oncologia, Ospedale Niguarda, Milano, ItalyEmail verificata su unimi.it
paola cassoniUniversità di torinoEmail verificata su unito.it
Andrea Sartore-BianchiClinical Molecular Oncology, Niguarda Cancer Center, Milano - ItalyEmail verificata su ospedaleniguarda.it
Federico BussolinoFull Professor of Biochemistry. Department of Oncology. University of Torino-ItalyEmail verificata su unito.it
Zsolt FeketeUniversity of Medicine and Pharmacy Iuliu Hatieganu, Institute of Oncology Prof Dr Ion ChiricutaEmail verificata su umfcluj.ro
Francesca OrzanIRCC - Institute for Cancer Research @ CandioloEmail verificata su ircc.it
Francesco G. BrunduStaff Bioinformatics Scientist, IlluminaEmail verificata su illumina.com
Sabrina ArenaIRCC-University of Torino Medical School Laboratory of Molecular Genetics S.P. 142, km 3.95 CandioloEmail verificata su ircc.it
Laura CantiniChargé de Recherce CNRS, Junior Group Leader (G5) Institut PasteurEmail verificata su pasteur.fr
Saverio TarditoCancer Research UK Beatson Institute, GlasgowEmail verificata su beatson.gla.ac.uk
Luigi MarchionniAssociate Professor of Pathology and Laboratory Medicine, Weill Cornell MedicineEmail verificata su med.cornell.edu
Lorenzo CapussottiChief of the Surgical Deparment- Ospedale Mauriziano "Umberto I" TorinoEmail verificata su mauriziano.it

Segui

Claudio Isella

IRCC

Email verificata su ircc.it

Functional Genomics


Titolo Ordina per citazioni Ordina per anno Ordina per titolo	Citata da Citata da	Anno
A molecularly annotated platform of patient-derived xenografts (“xenopatients”) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer A Bertotti, G Migliardi, F Galimi, F Sassi, D Torti, C Isella, D Corà, ... Cancer discovery 1 (6), 508-523, 2011	954*	2011
Stromal contribution to the colorectal cancer transcriptome C Isella, A Terrasi, SE Bellomo, C Petti, G Galatola, A Muratore, A Mellano, ... Nature genetics 47 (4), 312-319, 2015	606	2015
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets E Medico, M Russo, G Picco, C Cancelliere, E Valtorta, G Corti, ... Nature communications 6 (1), 7002, 2015	275	2015
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer C Isella, F Brundu, SE Bellomo, F Galimi, E Zanella, R Porporato, C Petti, ... Nature communications 8 (1), 15107, 2017	233	2017
Increased lactate secretion by cancer cells sustains non-cell-autonomous adaptive resistance to MET and EGFR targeted therapies M Apicella, E Giannoni, S Fiore, KJ Ferrari, D Fernández-Pérez, C Isella, ... Cell metabolism 28 (6), 848-865. e6, 2018	191	2018
MiR-1 Downregulation Cooperates with MACC1 in Promoting MET Overexpression in Human Colon Cancer C Migliore, V Martin, VP Leoni, A Restivo, L Atzori, A Petrelli, C Isella, ... Clinical Cancer Research 18 (3), 737-747, 2012	153	2012
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis H Ling, K Pickard, C Ivan, C Isella, M Ikuo, R Mitter, R Spizzo, MD Bullock, ... Gut 65 (6), 977-989, 2016	146	2016
Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlations F Galimi, D Torti, F Sassi, C Isella, D Corà, S Gastaldi, D Ribero, ... Clinical cancer research 17 (10), 3146-3156, 2011	137	2011
The thioxotriazole copper (II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells S Tardito, C Isella, E Medico, L Marchio, E Bevilacqua, M Hatzoglou, ... Journal of Biological Chemistry 284 (36), 24306-24319, 2009	134	2009
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts XY Woo, J Giordano, A Srivastava, ZM Zhao, MW Lloyd, R de Bruijn, ... Nature genetics 53 (1), 86-99, 2021	121	2021
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies ER Zanella, F Galimi, F Sassi, G Migliardi, F Cottino, SM Leto, B Lupo, ... Science translational medicine 7 (272), 272ra12-272ra12, 2015	112	2015
The miR-126 regulates angiopoietin-1 signaling and vessel maturation by targeting p85β R Sessa, G Seano, L Di Blasio, PA Gagliardi, C Isella, E Medico, F Cotelli, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1823 (10), 1925-1935, 2012	103	2012
MicroRNA–mRNA interactions underlying colorectal cancer molecular subtypes L Cantini, C Isella, C Petti, G Picco, S Chiola, E Ficarra, M Caselle, ... Nature communications 6 (1), 8878, 2015	81	2015
A molecular signature for Epithelial to Mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis T Joyce, D Cantarella, C Isella, E Medico, A Pintzas Clinical & experimental metastasis 26, 569-587, 2009	75	2009
A subset of colorectal cancers with cross-sensitivity to olaparib and oxaliplatin S Arena, G Corti, E Durinikova, M Montone, NM Reilly, M Russo, ... Clinical Cancer Research 26 (6), 1372-1384, 2020	70	2020
Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies S Rizzolio, G Cagnoni, C Battistini, S Bonelli, C Isella, ... The Journal of clinical investigation 128 (9), 3976-3990, 2018	60	2018
High USP6NL levels in breast cancer sustain chronic AKT phosphorylation and GLUT1 stability fueling aerobic glycolysis D Avanzato, E Pupo, N Ducano, C Isella, G Bertalot, C Luise, S Pece, ... Cancer research 78 (13), 3432-3444, 2018	60	2018
Prospective patient stratification into robust cancer‐cell intrinsic subtypes from colorectal cancer biopsies M Alderdice, SD Richman, S Gollins, JP Stewart, C Hurt, R Adams, ... The Journal of pathology 245 (1), 19-28, 2018	60	2018
MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases C Isella, A Mellano, F Galimi, C Petti, L Capussotti, M De Simone, ... Annals of surgery 257 (6), 1089-1095, 2013	60	2013
TNF-α promotes invasive growth through the MET signaling pathway V Bigatto, F De Bacco, E Casanova, G Reato, L Lanzetti, C Isella, I Sarotto, ... Molecular Oncology 9 (2), 377-388, 2015	58	2015

Il sistema al momento non può eseguire l'operazione. Riprova più tardi.

Articoli 1–20

Citazioni per anno

Citazioni duplicate

Citazioni unite

Aggiungi coautoriCoautori

Segui

Citata da

Coautori